Life Sciences

Biopharmaceutical company Mustang Bio has sold its 27,000-square-foot development, manufacturing, and testing facility in Worcester to a Boston firm specializing in cell-and-gene therapy for $11 million.

Waters Corp. completed the acquisition of Wyatt Technology, a light-scattering and field-flow fractionation instrument, software, services, and accessories company based in Santa Barbara, California.

Milford-based biotech Nitto Denko Avecia purchased two properties abutting its headquarters on Fortune Boulevard for $14.5 million.

Precisionary Instruments purchased a 12,000-square-foot flex unit in Ashland to relocate its headquarters from Natick.

Marlborough-based Akoya Biosciences posted a 26.6% increase in quarterly revenue in the first quarter compared to the same period last year, at $21.4 million.

Acton-based diabetes equipment manufacturer Insulet has reorganized its executive structure amid a 21% gain in first-quarter revenue. Jim Hollingshead will continue to lead the company as president and CEO.

Sunovion Pharmaceuticals and two other subsidiaries of the soon-to-be-combined Marlborough drugmaker Sumitomo Pharma America will lay off 223 workers as their Japanese parent company restructures the entire organization in America.

Marlborough medical technology company Hologic Inc. reported a 28.5% decrease in revenue in the second quarter, as compared to the same time period last year.

Milford life sciences equipment manufacturer Waters Corp. is among the top 10 companies in the state for gender diversity in executive leadership.

Cambridge-based drug manufacturer Moderna, Inc. has purchased a 140,000-square-foot biomanufacturing facility at 149 Hayes Memorial Drive in Marlborough.